EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Polydimethylsiloxane Organic–Inorganic Composite Drug Reservoir with Gliclazide

Ahmed Gedawy iD, Hani Al-Salami iD, Crispin R Dass iD

International Journal of Molecular Sciences · 03.04.2024 · 25 (7) · 3991

DOI: 10.3390/ijms25073991 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 03.04.2024. Verfasst von Ahmed Gedawy und 2 weiteren Autor:innen. Beteiligte Einrichtung: Curtin Medical School, Curtin University, Bentley 6102, Australia. Hauptthemen laut MEDLINE: Gliclazide. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Curtin University PGR Scholarship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A novel organic–inorganic gliclazide-loaded composite bead was developed by an ionic gelation process using acidified CaCl2, chitosan and tetraethylorthosilicate (TEOS) as a crosslinker. The beads were manufactured by crosslinking an inorganic silicone elastomer (-OH terminated polydimethylsiloxane, PDMS) with TEOS at different ratios before grafting onto an organic backbone (Na-alginate) using a 32 factorial experimental design. Gliclazide’s encapsulation efficiency (EE%) and drug release over 8 h (% DR 8 h) were set as dependent responses for the optimisation of a pharmaceutical formula (herein referred to as ‘G op’) by response surface methodology. EE % and %DR 8 h of G op were 93.48% ± 0.19 and 70.29% ± 0.18, respectively. G op exhibited a controlled release of gliclazide that follows the Korsmeyer–Peppas kinetic model (R2 = 0.95) with super case II transport and pH-dependent swelling behaviour. In vitro testing of G op showed 92.17% ± 1.18 cell viability upon testing on C2C12 myoblasts, indicating the compatibility of this novel biomaterial platform with skeletal muscle drug delivery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliclazideDimethylpolysiloxanesAlginatesBiocompatible Materials

Stichwörter der Autor:innen

PDMSchitosancomposite beadgliclazidemyoblastskeletal muscle

Substanzen

GliclazidebaysilonDimethylpolysiloxanesAlginatesBiocompatible Materials

Autor:innen und Institutionen

  • Curtin Medical School, Curtin University, Bentley 6102, Australia.
  • Curtin Health Innovation Research Institute, Curtin University, Bentley 6102, Australia.

ORCID-Profile: Ahmed Gedawy, Hani Al-Salami, Crispin R Dass

Förderung

  • Curtin University PGR Scholarship

Zitieren

APA

Gedawy, A., Al-Salami, H., & Dass, C. R. (2024). Polydimethylsiloxane Organic–Inorganic Composite Drug Reservoir with Gliclazide. International Journal of Molecular Sciences, 25(7), 3991. https://doi.org/10.3390/ijms25073991

Vancouver

Gedawy A, Al-Salami H, Dass CR. Polydimethylsiloxane Organic–Inorganic Composite Drug Reservoir with Gliclazide. International Journal of Molecular Sciences. 2024;25(7):3991. doi:10.3390/ijms25073991

BibTeX
@article{Gedawy2024,
  author = {Gedawy, Ahmed and Al-Salami, Hani and Dass, Crispin R},
  title = {Polydimethylsiloxane Organic–Inorganic Composite Drug Reservoir with Gliclazide},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {7},
  pages = {3991},
  doi = {10.3390/ijms25073991}
}
Kostenlos starten →